Headlines about Smith & Nephew (NYSE:SNN) have been trending somewhat positive recently, Accern Sentiment reports. The research group scores the sentiment of press coverage by analyzing more than 20 million blog and news sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Smith & Nephew earned a daily sentiment score of 0.22 on Accern’s scale. Accern also gave headlines about the medical equipment provider an impact score of 46.5236666507637 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.
A number of equities research analysts have weighed in on SNN shares. ValuEngine cut shares of Smith & Nephew from a “buy” rating to a “hold” rating in a research report on Friday, February 9th. Canaccord Genuity reiterated a “buy” rating on shares of Smith & Nephew in a research report on Thursday, February 8th. JPMorgan Chase & Co. upgraded shares of Smith & Nephew from a “neutral” rating to an “overweight” rating in a research report on Thursday, January 25th. Morgan Stanley cut shares of Smith & Nephew from an “overweight” rating to an “equal weight” rating in a research report on Monday, December 11th. Finally, Zacks Investment Research upgraded shares of Smith & Nephew from a “sell” rating to a “hold” rating in a research report on Wednesday, February 7th. Three equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. Smith & Nephew presently has an average rating of “Buy” and an average price target of $44.00.
Shares of Smith & Nephew (SNN) traded up $0.03 on Tuesday, hitting $37.57. 2,075,856 shares of the company’s stock were exchanged, compared to its average volume of 711,154. Smith & Nephew has a 1-year low of $30.35 and a 1-year high of $40.43. The company has a quick ratio of 1.06, a current ratio of 2.03 and a debt-to-equity ratio of 0.31.
About Smith & Nephew
Smith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. Its products and services include Sports Medicine Joint Repair, Arthroscopic Enabling Technologies (AET), Trauma & Extremities, Other Surgical Businesses, Knee Implants, Hip Implants, Advanced Wound Care, Advanced Wound Bioactives and Advanced Wound Devices.
Receive News & Ratings for Smith & Nephew Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew and related companies with MarketBeat.com's FREE daily email newsletter.